In this video from IDF 2015, Intel and Oregon Health & Science University (OHSU) announce the Collaborative Cancer Cloud, a precision medicine analytics platform that allows hospitals and research institutions to securely share patient genomic, imaging, and clinical data for potentially lifesaving discoveries.
The Collaborative Cancer Cloud is a precision medicine analytics platform that allows institutions to securely share patient genomic, imaging and clinical data for potentially lifesaving discoveries,” said Intel’s Eric Dishman. “It will enable large amounts of data from sites all around the world to be analyzed in a distributed way, while preserving the privacy and security of that patient data at each site. The end goal is to empower researchers and doctors to help patients receive a diagnosis based on their genome and potentially arm clinicians with the data needed for a targeted treatment plan. By 2020, we envision this happening in 24 hours — All in One Day. The focus is to help cancer centers worldwide—and eventually centers for other diseases—securely share their private clinical and research data with one another to generate larger datasets to benefit research and inform the specific treatment of their individual patients.”
As part of the announcement, Intel said that key technology components of the Collaborative Cancer Cloud (CCC) will be opened-sourced. The first technology releases will be made available to the developer community in Q1’16. Hospitals and research institutions of all sizes could use the technology to advance cancer research. They can also apply it to advance research in other diseases that have a genetic component, including Alzheimer’s, diabetes, Autism and more. Intel and OHSU also announced that they will partner with two other large cancer institutions to extend this capability in Q1’16.